|
US8263402B1
(en)
*
|
1998-10-19 |
2012-09-11 |
Cornell Research Foundation, Inc. |
Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells
|
|
US6667176B1
(en)
|
2000-01-11 |
2003-12-23 |
Geron Corporation |
cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
|
|
US7410798B2
(en)
|
2001-01-10 |
2008-08-12 |
Geron Corporation |
Culture system for rapid expansion of human embryonic stem cells
|
|
US20050042749A1
(en)
|
2001-05-16 |
2005-02-24 |
Carpenter Melissa K. |
Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease
|
|
IL152741A0
(en)
|
2000-05-17 |
2003-06-24 |
Geron Corp |
Neural progenitor cell populations
|
|
US7250294B2
(en)
|
2000-05-17 |
2007-07-31 |
Geron Corporation |
Screening small molecule drugs using neural cells differentiated from human embryonic stem cells
|
|
US6897061B1
(en)
*
|
2000-06-16 |
2005-05-24 |
Spinal Cord Society |
Transdifferentiation of glial cells
|
|
WO2003070171A2
(en)
|
2002-02-15 |
2003-08-28 |
Cornell Research Foundation, Inc. |
Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
|
|
US7207743B2
(en)
*
|
2002-05-28 |
2007-04-24 |
Polivka Parking Solutions Llc |
Method and apparatus for constructing an automotive vehicle parking lot
|
|
US7285415B2
(en)
|
2002-07-11 |
2007-10-23 |
The Regents Of The University Of California |
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
|
|
US20050101014A1
(en)
|
2002-07-11 |
2005-05-12 |
Keirstead Hans S. |
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
|
|
AR046076A1
(es)
*
|
2003-07-18 |
2005-11-23 |
Otsuka Pharma Co Ltd |
Procedimiento para obtener una poblacion homogenea de celulas precursoras de oligodendrocitos y poblacion obtenida
|
|
EP1682075A4
(en)
*
|
2003-11-07 |
2009-12-09 |
Univ Florida |
BREEDING AND DIFFERENTIATION OF NEURAL CREATOR CELLS
|
|
ES2491891T3
(es)
|
2004-01-16 |
2014-09-08 |
Carnegie Mellon University |
Marcaje celular para técnicas de resonancia magnética nuclear
|
|
GB2414995B
(en)
|
2004-06-09 |
2006-11-15 |
Univ Edinburgh |
Neural stem cells
|
|
JP2008526916A
(ja)
*
|
2005-01-19 |
2008-07-24 |
フィディア アドバンスド バイオポリマーズ ソシエタ ア レスポンサビリタ リミタータ |
Ｓｃｉおよびｐｎｔ再生のためのヒアルロン酸誘導体および神経幹細胞
|
|
US7803364B2
(en)
|
2005-11-17 |
2010-09-28 |
The Cleveland Clinic Foundation |
Multipotent neural stem cells
|
|
WO2008054509A2
(en)
*
|
2006-04-14 |
2008-05-08 |
Celsense, Inc. |
Methods for assessing cell labeling
|
|
CA2649333C
(en)
*
|
2006-04-14 |
2016-10-04 |
Carnegie Mellon University |
Cellular labeling and quantification for nuclear magnetic resonance techniques
|
|
JP2010500047A
(ja)
|
2006-08-15 |
2010-01-07 |
エージェンシー フォー サイエンス，テクノロジー アンド リサーチ |
間葉系幹細胞馴化培地
|
|
US8163075B2
(en)
|
2006-10-31 |
2012-04-24 |
Sensient Colors Llc |
Inks comprising modified pigments and methods for making and using the same
|
|
AU2008242987A1
(en)
*
|
2007-04-17 |
2008-10-30 |
University Of Rochester |
Telencephalic glial-restricted cell populations and related compositions and methods
|
|
AU2008275578B2
(en)
*
|
2007-07-10 |
2014-04-10 |
Carnegie Mellon University |
Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques
|
|
EP3483222A3
(en)
|
2007-08-23 |
2019-08-07 |
Sensient Colors LLC |
Self-dispersed pigments and methods for making and using the same
|
|
US8513009B2
(en)
|
2008-01-30 |
2013-08-20 |
Geron Corporation |
Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells
|
|
SG188918A1
(OSRAM)
|
2008-03-17 |
2013-04-30 |
Agency Science Tech & Res |
|
|
AU2009241762B2
(en)
*
|
2008-05-02 |
2015-07-16 |
Celsense Inc. |
Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
|
|
US9709553B2
(en)
|
2008-05-08 |
2017-07-18 |
University Of Rochester |
Treating myelin diseases with optimized cell preparations
|
|
US9688956B2
(en)
|
2008-06-05 |
2017-06-27 |
National Cheng Kung University |
Method for preserving proliferation and differentiation potential of mesenchymal stem cells
|
|
WO2010008486A2
(en)
|
2008-06-24 |
2010-01-21 |
Parkinsons Institute |
Pluripotent cell lines and methods of use thereof
|
|
WO2010068946A1
(en)
*
|
2008-12-12 |
2010-06-17 |
Nova Southeastern University |
Methods of isolating and using stem cells
|
|
CN102325878A
(zh)
|
2008-12-23 |
2012-01-18 |
斯特姆塞尔思加利福尼亚有限公司 |
少突胶质前体细胞的靶向细胞群及制备与使用方法
|
|
JP2012523479A
(ja)
|
2009-04-07 |
2012-10-04 |
センシエント カラーズ エルエルシー |
自己分散性粒子並びにその製造方法及び使用方法
|
|
EP2456853B1
(en)
|
2009-07-21 |
2020-10-28 |
ABT Holding Company |
Use of stem cells to reduce leukocyte extravasation
|
|
US20110020292A1
(en)
|
2009-07-21 |
2011-01-27 |
Abt Holding Company |
Use of Stem Cells to Reduce Leukocyte Extravasation
|
|
NZ602174A
(en)
*
|
2010-02-05 |
2014-10-31 |
Auckland Uniservices Ltd |
Cell programming
|
|
SG183497A1
(en)
|
2010-02-25 |
2012-09-27 |
Abt Holding Co |
Modulation of macrophage activation
|
|
US8895291B2
(en)
|
2010-10-08 |
2014-11-25 |
Terumo Bct, Inc. |
Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
|
|
US8433419B2
(en)
|
2010-10-13 |
2013-04-30 |
Cardiac Pacemakers, Inc. |
Method and apparatus for controlling neurostimulation according to physical state
|
|
WO2012168295A1
(en)
|
2011-06-06 |
2012-12-13 |
ReGenesys BVBA |
Expansion of stem cells in hollow fiber bioreactors
|
|
WO2014124087A1
(en)
|
2013-02-06 |
2014-08-14 |
University Of Rochester |
Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders
|
|
US9896656B2
(en)
|
2013-03-15 |
2018-02-20 |
Wake Forest University Health Sciences |
Neural progenitor cell differentiation
|
|
PT2983680T
(pt)
|
2013-04-12 |
2020-10-29 |
Abt Holding Co |
Melhoria de órgãos para transplante
|
|
ES2753323T3
(es)
|
2013-04-30 |
2020-04-08 |
Univ Leuven Kath |
Terapia celular para síndromes mielodisplásicos
|
|
JP6612227B2
(ja)
|
2013-11-16 |
2019-11-27 |
テルモ ビーシーティー、インコーポレーテッド |
バイオリアクターにおける細胞増殖
|
|
US9724432B2
(en)
|
2015-04-30 |
2017-08-08 |
University Of Rochester |
Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
|
|
WO2017147212A1
(en)
|
2016-02-22 |
2017-08-31 |
The Regents Of The University Of California |
Compositions and methods for imaging cell populations
|
|
CN109219657A
(zh)
|
2016-03-30 |
2019-01-15 |
阿斯特利亚斯生物治疗股份公司 |
少突胶质细胞祖细胞组合物
|
|
EP4549457A3
(en)
*
|
2017-01-31 |
2025-05-28 |
Osaka University |
Differentiation control method for pluripotent stem cells
|
|
JP7457505B2
(ja)
|
2017-05-10 |
2024-03-28 |
ユニバーシティー オブ ロチェスター |
神経精神障害を処置する方法
|
|
IL281628B2
(en)
|
2018-09-19 |
2025-06-01 |
Lineage Cell Therapeutics Inc |
Methods for differentiating pluripotent stem cells in dynamic suspension culture
|
|
US11603518B2
(en)
*
|
2019-01-23 |
2023-03-14 |
Asterias Biotherapeutics, Inc. |
Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells
|
|
JP7728747B2
(ja)
|
2019-08-23 |
2025-08-25 |
サナ バイオテクノロジー，インコーポレイテッド |
Ｃｄ２４発現細胞およびそれらの用途
|
|
BR112022019060A2
(pt)
|
2020-03-25 |
2022-11-29 |
Sana Biotechnology Inc |
Células neurais hipoimunogênicas para o tratamento de distúrbios e condições neurológicas
|
|
IL300516A
(en)
|
2020-08-13 |
2023-04-01 |
Sana Biotechnology Inc |
Methods for treating susceptible patients with hypoimmunogenic cells, and related methods and compounds
|
|
BR112023024434A2
(pt)
|
2021-05-27 |
2024-02-20 |
Sana Biotechnology Inc |
Células hipoimunogênicas que compreendem hla-e ou hla-g geneticamente modificadas
|
|
EP4370544A2
(en)
|
2021-07-14 |
2024-05-22 |
Sana Biotechnology, Inc. |
Altered expression of y chromosome-linked antigens in hypoimmunogenic cells
|
|
AU2022325955A1
(en)
|
2021-08-11 |
2024-02-08 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy to reduce instant blood mediated inflammatory reactions
|
|
WO2023019226A1
(en)
|
2021-08-11 |
2023-02-16 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy
|
|
MX2024001443A
(es)
|
2021-08-11 |
2024-05-15 |
Sana Biotechnology Inc |
Sistemas inducibles para alterar la expresión génica en células hipoinmunógenas.
|
|
JP2024534771A
(ja)
|
2021-08-11 |
2024-09-26 |
サナ バイオテクノロジー，インコーポレイテッド |
補体媒介性炎症反応を低減するための同種異系細胞療法のための遺伝子改変細胞
|
|
WO2023183313A1
(en)
|
2022-03-22 |
2023-09-28 |
Sana Biotechnology, Inc. |
Engineering cells with a transgene in b2m or ciita locus and associated compositions and methods
|
|
WO2025054202A1
(en)
|
2023-09-05 |
2025-03-13 |
Sana Biotechnology, Inc. |
Method of screening a sample comprising a transgene with a unique barcode
|
|
WO2025151838A1
(en)
|
2024-01-12 |
2025-07-17 |
Sana Biotechnology, Inc. |
Safety switches to control in vitro and in vivo proliferation of cell therapy products
|